PDF Print-Friendly PDF

Jared Sturgeon, M.D., Ph.D.

Provider Type:
  • Physician
Specialties:
  • Proton Therapy
  • Radiation Oncology for Adults
  • Radiation Oncology for Pediatrics

Background / Education

  • Fellowship in Proton Radiation Oncology
    The University of Texas MD Anderson Cancer Center, Houston, Texas
  • Residency in Radiation Oncology
    The University of Texas Medical Branch at Galveston, Texas, and The University of Texas MD Anderson Cancer Center, Houston, Texas
  • Internship in Internal Medicine
    University of North Dakota, Grand Forks, N.D.
  • Medical Doctorate
    University of Minnesota Twin Cities, Minneapolis, Minn.
  • Philosophy Doctorate in Epidemiology
    University of Minnesota Twin Cities, Minneapolis, Minn.

Memberships / Honors / Awards

  • American Society of Clinical Oncology
  • American Society of Therapeutic Radiation Oncology
  • Radiological Society of North America
  • American Radium Society
  • American Brachytherapy Society

Summary

Dr. Jared Sturgeon became a radiation oncologist after working closely with cancer patients during his medical school training at University of Minnesota Twin Cities. He completed his training in radiation oncology in Texas and after his residency, completed a fellowship in proton therapy under the direction of medical director, Dr. Andrew Lee, at The University of Texas MD Anderson Cancer Center in Houston. Dr. Sturgeon accepted his first position at the Karamanos McLaren Proton Therapy Center in Flint, Mich. The draw of returning to Texas was too great, and in 2015 Dr. Sturgeon relocated his family to the lone star state to join the team at Texas Center for Proton Therapy.

Dr. Sturgeon’s clinical research interests include proton toxicity outcomes, advanced imaging and human reproducibility, and cancer population etiologies. He is interested in medical education and created an online database to help residents pass their medical boards.

Dr. Sturgeon has a special interest in treating breast, head and neck, pediatric, and lung cancers.  He is passionate about working closely with patients as they undergo cancer therapy. Dr. Sturgeon understands that every person and cancer is unique and works hard to ensure that each patient receives high quality care.


What are three things you would like your patients to know about you?
I love being a part of a patient’s individual cancer journey, and I am always humbled to be a part of a patient’s care team. I am grateful to live in an age where we are making so much progress in cancer care – from proton therapy to immunotherapy, there have been great strides in advancing treatment options for all cancer types. And, fun fact, I am lucky enough to have seven children.

What made you interested in working with proton therapy?
I have always been interested in leading-edge technology, and I have had a passion for caring for cancer patients. Those reasons combined led me to this field of medicine. Proton therapy is on the forefront of radiation and I wanted to continue growing my knowledge and experience with that technological edge. I have always wanted to make sure that patients could return to a life that is as normal as possible, with the fewest side effects after treatment. As a radiation oncologist, I feel responsible not just for helping them with their cancer diagnosis, but also for ensuring that side effects do not linger or cause secondary issues. I was drawn to proton therapy because of the possibility of helping patients recover with as little disruption to their quality of life as possible.

Publications

  • Definitive Chemoradiation for Squamous Cell Carcinoma of the Rectum.

    American Journal of Clinical Oncology, 2014

  • Improved human observer performance in digital reconstructed radiograph verification in head and neck cancer radiotherapy.

    International Journal of Computer Assisted Radiology and Surgery, 2014

  • Hemostatic and Inflammatory Risk Factors for Intracerebral Hemorrhage in a Pooled Study.

    Stroke, 2008

  • Risk Factors for lntracerebral Hemorrhage in a Pooled Prospective Study.

    Stroke, 2007

  • Trends in the hospitalization rate, hospital case fatality, and mortality rate of stroke by subtype in Minneapolis-St Paul.

    Neuroepidemiology, 2007

Show all Publications
  • Toward a better understanding of the comparatively high prostate cancer incidence rates in Utah.

    BMC Cancer, 2003

  • Apolipoprotein E Genotype and Incident lschemic Stroke. The Athersosclerosis Risk in Communities Study.

    Stroke, 2003

Request An Appointment

Texas Center for Proton Therapy is ready to help you fight cancer with one of the nation’s most advanced cancer-fighting technologies. You do not need a doctor's referral to be seen at the center.

Request an Appointment